Press release
Drug Eluting Balloon Market: Accelerating Growth Towards US$ 1.0 Bn, Expanding at a CAGR of 7.1% by 2031 - TMR Insights
The drug eluting balloon (DEB) market has emerged as a vital segment in the interventional cardiology and peripheral artery disease (PAD) treatment landscape. The increasing prevalence of cardiovascular disorders and the demand for minimally invasive treatment options have propelled the adoption of DEBs globally.The global drug eluting balloon market was valued at US$ 571.1 million in 2022 and is projected to expand at a CAGR of 7.1% from 2023 to 2031, reaching approximately US$ 1.0 billion by the end of 2031. The market's growth is fueled by advancements in medical technology, increasing preference for non-stent-based treatment alternatives, and rising awareness about effective cardiovascular care.
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2321
Analyst Viewpoint
Experts anticipate significant expansion in the DEB market due to the rising burden of cardiovascular diseases, an aging population, and technological innovations in catheter-based treatment approaches. While the market faces challenges such as regulatory hurdles and high device costs, increased research funding and favorable reimbursement policies are expected to drive further adoption.
Key Market Drivers
Rising Prevalence of Cardiovascular Diseases - Increased cases of coronary and peripheral artery diseases boost demand.
Advancements in Balloon Catheter Technology - Development of next-generation DEBs enhances treatment efficacy.
Growing Preference for Minimally Invasive Procedures - Reduced recovery time and lower complication risks attract more patients.
Favorable Reimbursement Policies - Increased insurance coverage supports patient affordability and access.
Surge in Clinical Trials and Approvals - Continuous R&D efforts improve product innovation and regulatory acceptance.
Recent Developments
2023: Medtronic launched an advanced paclitaxel-coated DEB for peripheral artery disease treatment.
2022: Boston Scientific expanded its product portfolio with a new FDA-approved DEB for coronary interventions.
2021: B. Braun received regulatory clearance in Europe for its next-generation DEB featuring improved drug delivery.
2020: Abbott collaborated with leading research institutions to explore novel drug formulations for DEBs.
2019: BD acquired a medical device firm to strengthen its interventional cardiology segment.
Key Players
Bayer AG
Medtronic
B. Braun Melsungen AG
Cook Medical, Inc.
Boston Scientific Corporation
Becton, Dickson and Company
EuroCor
Terumo Corporation
Koninklijke Philips N.V.
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2321
Market Trends and Opportunities
Adoption of Biodegradable Drug Coatings - Next-gen DEBs with bioresorbable coatings gaining traction.
Growing Focus on Emerging Markets - Expanding healthcare infrastructure in Asia-Pacific and Latin America.
Expansion of Indications Beyond Cardiology - Increasing DEB use in vascular and non-vascular interventions.
Rising Investment in R&D - Companies investing in novel drug combinations to enhance efficacy.
Collaborations Between MedTech Firms and Hospitals - Partnerships driving innovation and clinical adoption.
Market Segmentation
By Application
Coronary Artery Disease
Peripheral Artery Disease
By End-Use
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Future Outlook
The drug eluting balloon market is poised for robust growth, driven by continuous technological advancements and expanding treatment applications. As healthcare providers and policymakers emphasize minimally invasive solutions, the demand for DEBs is expected to rise steadily in the coming years.
Regional Analysis
North America - Leading market due to high adoption rates and advanced healthcare infrastructure.
Europe - Significant growth driven by regulatory approvals and reimbursement policies.
Asia-Pacific - Fastest-growing region with increasing investments in cardiovascular healthcare.
Latin America & Middle East & Africa - Emerging markets with untapped potential for DEB adoption.
Explore Latest Research Reports by Transparency Market Research:
Hormone Replacement Therapy Market: https://www.pharmiweb.com/press-release/2025-03-12/hormone-replacement-therapy-market-to-reach-us-388-billion-by-2034-driven-by-increasing-demand-for-menopause-and-endocrine-disorder-treatments-tm
Sexually Transmitted Diseases (STD) Diagnostics Market: https://www.pharmiweb.com/press-release/2025-03-12/sexually-transmitted-diseases-std-diagnostics-market-to-exceed-us-159-billion-by-2034-fueled-by-innovation-and-rising-awareness-tmr-insights
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Eluting Balloon Market: Accelerating Growth Towards US$ 1.0 Bn, Expanding at a CAGR of 7.1% by 2031 - TMR Insights here
News-ID: 3950895 • Views: …
More Releases from Transparency Market Research
Global SiC Ceramics Market Poised for Robust Growth, Projected to Reach USD 3.1 …
The global silicon carbide (SiC) ceramics market continues to demonstrate strong growth potential, underpinned by accelerating demand from advanced industrial and electronic applications. Valued at US$ 1.8 Billion in 2024, the market is projected to reach US$ 3.1 Billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2025 to 2035. This steady expansion reflects the increasing importance of SiC ceramics as…
Furfuryl Alcohol Market to Reach USD 1.34 Billion by 2035, Supported by Rising D …
The global Furfuryl Alcohol Market was valued at US$ 624.3 million in 2024 and is projected to reach US$ 1,341.2 million by 2035, expanding at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2035.
This growth is primarily driven by the rising demand for bio-based and sustainable chemicals, along with the steady expansion of the foundry and metal casting industry, particularly across emerging economies in Asia Pacific.
Gain a…
Air-Entraining Agents Market Outlook 2035: Forecast to Reach US$ 2.48 Billion by …
The global Air-Entraining Agents (AEAs) Market was valued at US$ 1.70 billion in 2024 and is projected to reach US$ 2.48 billion by 2035, expanding at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2035. This steady growth trajectory reflects the essential role AEAs play in modern concrete formulations, particularly in infrastructure projects that demand long-term durability, freeze-thaw resistance, and improved workability.
Despite being a mature segment within…
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn …
The global Application-to-Person (A2P) SMS market is entering a phase of steady and resilient expansion, driven by the growing need for secure, reliable, and real-time communication between enterprises and consumers. Valued at US$ 71.2 Bn in 2024, the market is projected to reach US$ 117.0 Bn by 2035, expanding at a CAGR of 4.2% from 2025 to 2035. Despite the rise of internet-based messaging platforms, A2P SMS continues to maintain…
More Releases for DEB
Dystrophic Epidermolysis Bullosa (DEB) Market Emerging Trends and Growth Prospec …
Introduction
Dystrophic epidermolysis bullosa (DEB) is a rare and debilitating genetic skin disorder characterized by extreme fragility of the skin and mucous membranes, leading to chronic blistering, painful wounds, and scarring. Classified as a rare or "orphan" disease, DEB severely impacts quality of life, often resulting in severe complications including infections, malnutrition, and increased risk of squamous cell carcinoma.
Over the past decade, advances in genetic research, regenerative medicine, and biologic therapies…
Drug Eluting Balloons (DEB) Market Future Business Scope Analysis Report, Market …
"The global Drug Eluting Balloons (DEB) market is projected to reach approximately $1.2 billion in 2024, driven by increasing cardiovascular disease prevalence and the rising demand for minimally invasive procedures. The market is anticipated to experience significant growth, with an estimated compound annual growth rate (CAGR) of 9.5% from 2025 to 2034, potentially reaching around $2.7 billion by the end of this period."
Exactitude Consultancy., Ltd. released a research report titled…
Infection Surveillance Solutions Market SWOT Analysis by Leading Expert: GOJO, D …
The "Infection Surveillance Solutions Market" intelligence report, just published by USD Analytics Market, covers a micro-level study of important market niches, product offers, and sales channels. to determine market size, potential, growth trends, and competitive environment, the Infection Surveillance Solutions Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the…
Author's Tranquility Press Presents: "Jungle Buddies" by Deb Annie
A Heartwarming Tale of Friendship and Growth in the Animal Kingdom
Author's Tranquility Press is excited to announce the release of "Jungle Buddies [https://www.amazon.com/Jungle-Buddies-Deb-Annie-ebook/dp/B0D3DQN7S3/ref=sr_1_1?crid=2F9SJVXYJV84E&dib=eyJ2IjoiMSJ9.48U5EPHJnPRre0UDLIeiYg.alNqml8vpCXVNFr9kWCB-V3OJRJ9_wf0AsYNOPR9prs&dib_tag=se&keywords=979-8369417522&qid=1718058770&s=books&sprefix=979-8369417522%2Cstripbooks%2C549&sr=1-1]," an enchanting new children's book by Deb Annie. This delightful story follows the adventures of Lenny, a cautious but curious lion cub, as he learns valuable life lessons under the guidance of Lionel, an older and wiser lion.
"Jungle Buddies" is a heartwarming tale that captures the essence…
Drug Eluting Balloons (DEB) Market Recently Updated Research Report, Growth till …
Drug Eluting Balloons (DEB) Market Overview 2023-2030:
The Drug Eluting Balloons (DEB) Market Report can be segmented based on the type of encoder (absolute or incremental), output and application (consumer electronics, automotive, industrial, healthcare, aerospace and defense, and others). The Market segment is expected to witness significant growth due to the increasing demand for Drug Eluting Balloons (DEB) and others. Explanation of the primary tactics used by the participants, including partnerships, mergers, and…
Deb Della Piana is Art Gallery's New Featured Artist
Jupiter, FL, USA -- Light Space & Time Online Art Gallery is very pleased to announce that Deb Della Piana is the gallery's new featured artist and for the next 30 days will be promoted in the gallery's artist showcase. Deb is a Massachusetts based fine art photographer.
It wasn't until sometime in 2012 that Deb started seriously thinking about pursuing photography. Since the fall of 2014, Deb has held two…
